The use of regulatory “sandboxes” to test out new approaches to the development and assessment of novel medicines could become widespread in the EU if proposals for the overhaul of the pharmaceutical legislation are approved.
Sandboxes could allow highly innovative products or technologies to be tested using novel regulatory tools as well as real-world evidence, with the necessary safeguards in place
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?